VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Feb 19, 2020
Document Date
Feb 14, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Mitchell Stephen Ray
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |